Quantitative analysis of murine terminal erythroid differentiation in vivo:novelmethod to study normal and disordered erythropoiesis

Blood

Volumn 121, Issue 8, 2013, Pages

  Liu, Jing ^a,b   Zhang, Jianhua ^a   Ginzburg, Yelena ^a   Li, Huihui ^a   Xue, Fumin ^a   De Franceschi, Lucia ^c   Chasis, Joel Anne ^a   Mohandas, Narla ^a   An, Xiuli ^a  

^a NEW YORK BLOOD CENTER   (United States)

^b CENTRAL SOUTH UNIVERSITY   (China)

^c UNIVERSITY OF VERONA   (Italy)

Author keywords

Quantitative analysis of erythropoiesis of thalassemia mice revealed stage specific changes in terminal erythroid differentiation.; The study establishes a reliable method to quantify differentiating mouse erythroblasts and to monitor terminal mouse erythropoiesis in vivo

Indexed keywords

HERMES ANTIGEN;

ANEMIA; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BONE MARROW; CELL DIFFERENTIATION; CELL SIZE; CONTROLLED STUDY; ERYTHROID CELL; ERYTHROPOIESIS; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SPLEEN;

EID: 84874354874     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2012-09-456079     Document Type: Article

References (31)

1. Stephenson JR, Axelrad AA, McLeod DL, Shreeve MM. Induction of colonies of hemoglobin-synthesizing cells by erythropoietin in vitro. Proc Natl Acad Sci U S A. 1971;68(7): 1542-1546.
2. McLeod DL, Shreeve MM, Axelrad AA. Improved plasma culture system for production of erythrocytic colonies in vitro: quantitative assay method for CFU-E. Blood. 1974;44(4):517-534.
3. Heath DS, Axelrad AA, McLeod DL, Shreeve MM. Separation of the erythropoietin-responsive progenitors BFU-E and CFU-E in mouse bone marrow by unit gravity sedimentation. Blood. 1976; 47(5):777-792.
4. Dover GJ, Chan T, Sieber F. Fetal hemoglobin production in cultures of primitive and mature human erythroid progenitors: differentiation affects the quantity of fetal hemoglobin produced per fetal-hemoglobin-containing cell. Blood. 1983; 61(6):1242-1246. (Pubitemid 13099915)
5. Socolovsky M, Nam H, Fleming MD, Haase VH, Brugnara C, Lodish HF. Ineffective erythropoiesis in Stat5a(-/-)5b(-/-) mice due to decreased survival of early erythroblasts. Blood. 2001; 98(12):3261-3273.
6. Liu Y, Pop R, Sadegh C, Brugnara C, Haase VH, Socolovsky M. Suppression of Fas-FasL coexpression by erythropoietin mediates erythroblast expansion during the erythropoietic stress response in vivo. Blood. 2006;108(1):123-133. (Pubitemid 43990620)
7. Kinross KM, Clark AJ, Iazzolino RM, Humbert PO. E2f4 regulates fetal erythropoiesis through the promotion of cellular proliferation. Blood. 2006; 108(3):886-895. (Pubitemid 44154621)
8. Minella AC, Loeb KR, Knecht A, et al. Cyclin E phosphorylation regulates cell proliferation in hematopoietic and epithelial lineages in vivo. Genes Dev. 2008;22(12):1677-1689. (Pubitemid 351846846)
9. Halupa A, Bailey ML, Huang K, Iscove NN, Levy DE, Barber DL. A novel role for STAT1 in regulating murine erythropoiesis: deletion of STAT1 results in overall reduction of erythroid progenitors and alters their distribution. Blood. 2005;105(2):552-561. (Pubitemid 40070736)
10. Nagano M, Yamamoto M. Transgene insertion in proximity to the c-myb gene disrupts erythroidmegakaryocytic lineage bifurcation. Mol Cell Biol. 2006;26(21):7953-7965. (Pubitemid 44630995)
11. Diwan A, Koesters AG, Odley AM, et al. Unrestrained erythroblast development in Nix-/- mice reveals a mechanism for apoptotic modulation of erythropoiesis. Proc Natl Acad Sci U S A. 2007;104(16):6794-6799. (Pubitemid 47175580)
12. Hosoya-Ohmura S, Mochizuki N, Suzuki M, Ohneda O, Ohneda K, Yamamoto M. GATA-4 incompletely substitutes for GATA-1 in promoting both primitive and definitive erythropoiesis in vivo. J Biol Chem. 2006;281(43):32820-32830. (Pubitemid 46036837)
13. Chen K, Liu J, Heck S, Chasis JA, An X, Mohandas N. Resolving the distinct stages in erythroid differentiation based on dynamic changes in membrane protein expression during erythropoiesis. Proc Natl Acad Sci U S A. 2009;106(41):17413-17418.
14. Shi ZT, Afzal V, Coller B, et al. Protein 4.1Rdeficient mice are viable but have erythroid membrane skeleton abnormalities. J Clin Invest. 1999; 103(3):331-340. (Pubitemid 29069982)
15. Skow LC, Burkhart BA, Johnson FM, et al. A mouse model for beta-thalassemia. Cell. 1983; 34(3):1043-1052.
16. Joiner CH, Franco RS, Jiang M, Franco MS, Barker JE, Lux SE. Increased cation permeability in mutant mouse red blood cells with defective membrane skeletons. Blood. 1995;86(11):4307-4314.
17. Li H, Rybicki AC, Suzuka SM, et al. Transferrin therapy ameliorates disease in beta-thalassemic mice. Nat Med. 2010;16(2):177-182.
18. Centis F, Tabellini L, Lucarelli G, et al. The importance of erythroid expansion in determining the extent of apoptosis in erythroid precursors in patients with beta-thalassemia major. Blood. 2000; 96(10):3624-3629.
19. Rund D, Rachmilewitz E. Beta-thalassemia. N Engl J Med. 2005;353(11):1135-1146.
20. Alfarano C, Andrade CE, Anthony K, et al. The Biomolecular Interaction Network Database and related tools 2005 update. Nucleic Acids Res. 2005;33(database issue):D418-424.
21. Carmichael CL, Majewski IJ, Alexander WS, et al. Hematopoietic defects in the Ts1Cje mouse model of Down syndrome. Blood. 2009;113(9):1929-1937.
22. Chen ML, Logan TD, Hochberg ML, et al. Erythroid dysplasia, megaloblastic anemia, and impaired lymphopoiesis arising from mitochondrial dysfunction. Blood. 2009;114(19):4045-4053.
23. Cheloufi S, Dos Santos CO, Chong MM, Hannon GJ. A dicer-independent miRNA biogenesis pathway that requires Ago catalysis. Nature. 2010;465(7298):584-589.
24. Guihard S, Clay D, Cocault L, et al. The MAPK ERK1 is a negative regulator of the adult steadystate splenic erythropoiesis. Blood. 2010;115(18): 3686-3694.
25. Kalfa TA, Pushkaran S, Zhang X, et al. Rac1 and Rac2 GTPases are necessary for early erythropoietic expansion in the bone marrow but not in the spleen. Haematologica. 2010;95(1):27-35.
26. Martin FM, Xu X, von Lohneysen K, Gilmartin TJ, Friedman JS. SOD2 deficient erythroid cells upregulate transferrin receptor and down-regulate mitochondrial biogenesis and metabolism. PLoS One. 2011;6(2):e16894.
27. Maragno AL, Pironin M, Alcalde H, et al. ISG15 modulates development of the erythroid lineage. PLoS One. 2011;6(10):e26068.
28. Ripich T, Jessberger R. SWAP-70 regulates erythropoiesis by controlling alpha4 integrin. Haematologica. 2011;96(12):1743-1752.
29. Oliva EN, Ronco F, Marino A, Alati C, Pratico G, Nobile F. Iron chelation therapy associated with improvement of hematopoiesis in transfusiondependent patients. Transfusion. 2010;50(7): 1568-1570.
30. Ricchi P, Ammirabile M, Costantini S, et al.Auseful relationship between the presence of extramedullary erythropoeisis and the level of the soluble form of the transferrin receptor in a large cohort of adult patients with thalassemia intermedia: a prospective study. Ann Hematol. 2012;91(6):905-909.
31. Beguin Y. Soluble transferrin receptor for the evaluation of erythropoiesis and iron status. Clin Chim Acta. 2003;329(1-2):9-22. (Pubitemid 36183479)